GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Omnimmune Holdings Inc (GREY:OMMH) » Definitions » Gross Margin %

Omnimmune Holdings (Omnimmune Holdings) Gross Margin % : 0.00% (As of Sep. 2010)


View and export this data going back to 2007. Start your Free Trial

What is Omnimmune Holdings Gross Margin %?

Gross Margin % is calculated as gross profit divided by its revenue. Omnimmune Holdings's Gross Profit for the three months ended in Sep. 2010 was $0.00 Mil. Omnimmune Holdings's Revenue for the three months ended in Sep. 2010 was $0.00 Mil. Therefore, Omnimmune Holdings's Gross Margin % for the quarter that ended in Sep. 2010 was 0.00%. If there's no value for Cost of Goods Sold, then Gross Margin % is not calculated.


The historical rank and industry rank for Omnimmune Holdings's Gross Margin % or its related term are showing as below:


OMMH's Gross Margin % is not ranked *
in the Biotechnology industry.
Industry Median: 59.74
* Ranked among companies with meaningful Gross Margin % only.

Omnimmune Holdings had a gross margin of N/A% for the quarter that ended in Sep. 2010 => No sustainable competitive advantage

The 5-Year average Growth Rate of Gross Margin for Omnimmune Holdings was 0.00% per year.


Omnimmune Holdings Gross Margin % Historical Data

The historical data trend for Omnimmune Holdings's Gross Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Omnimmune Holdings Gross Margin % Chart

Omnimmune Holdings Annual Data
Trend May07 May08 Dec09
Gross Margin %
- - -

Omnimmune Holdings Quarterly Data
May07 Aug07 Nov07 Feb08 May08 Aug08 Dec08 Mar09 Jun09 Sep09 Dec09 Mar10 Jun10 Sep10
Gross Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Omnimmune Holdings's Gross Margin %

For the Biotechnology subindustry, Omnimmune Holdings's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Omnimmune Holdings's Gross Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Omnimmune Holdings's Gross Margin % distribution charts can be found below:

* The bar in red indicates where Omnimmune Holdings's Gross Margin % falls into.



Omnimmune Holdings Gross Margin % Calculation

Gross Margin is the percentage of Gross Profit out of sales or Revenue. (Note that if there's no value for Cost of Goods Sold, then Gross Margin % is not calculated.)

Omnimmune Holdings's Gross Margin for the fiscal year that ended in Dec. 2009 is calculated as

Gross Margin % (A: Dec. 2009 )=Gross Profit (A: Dec. 2009 ) / Revenue (A: Dec. 2009 )
=0 / 0
=(Revenue - Cost of Goods Sold) / Revenue
=(0 - 0) / 0
=N/A %

Omnimmune Holdings's Gross Margin for the quarter that ended in Sep. 2010 is calculated as


Gross Margin % (Q: Sep. 2010 )=Gross Profit (Q: Sep. 2010 ) / Revenue (Q: Sep. 2010 )
=0 / 0
=(Revenue - Cost of Goods Sold) / Revenue
=(0 - 0) / 0
=N/A %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


Omnimmune Holdings  (GREY:OMMH) Gross Margin % Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Omnimmune Holdings had a gross margin of N/A% for the quarter that ended in Sep. 2010 => No sustainable competitive advantage


Be Aware

If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.


Omnimmune Holdings Gross Margin % Related Terms

Thank you for viewing the detailed overview of Omnimmune Holdings's Gross Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Omnimmune Holdings (Omnimmune Holdings) Business Description

Traded in Other Exchanges
N/A
Address
4600 Post Oak Place, Suite 352, Houston, TX, USA, 77027
Website
Omnimmune Holdings Inc is a development-stage biotechnology company, which is engaged in integrating complementary cancer therapeutic, diagnostic and prognostic technologies.

Omnimmune Holdings (Omnimmune Holdings) Headlines

No Headlines